However, it should be noted that DNAse-1—despite its apparent benefits in accelerating the breakdown of coronary and cerebral thrombi—has in cases been harmful to bronchiectasis patients in one clinical trial (151). The gene discussed is DNASE1; the disease is bronchiectasis.